FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

PJ Ferguson

Research Profile

Anatomy

Living Beings

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Craig L Bennett; J Christie; Fred Ramsdell; Mary E Brunkow; PJ Ferguson; Luke Whitesell; TE Kelly; Frank T Saulsbury; Phillip F Chance; Hans D Ochs
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.
PJ Ferguson; S Blanton; Frank T Saulsbury; Marcia McDuffie; V Lemahieu; Julie M Gastier-Foster; Uta Francke; Stephen M Borowitz; James L Sutphen; TE Kelly
Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome.
ML Reinagel; M Gezen; PJ Ferguson; SE Kuhn; Edward N Martin; Ronald P Taylor
The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of PJ Ferguson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Craig L Bennett; J Christie; Fred Ramsdell; Mary E Brunkow; PJ Ferguson; Luke Whitesell; TE Kelly; Frank T Saulsbury; Phillip F Chance; Hans D Ochs
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3.
Nature genetics 2001;27(1):20-1.
2000: PJ Ferguson; S Blanton; Frank T Saulsbury; Marcia McDuffie; V Lemahieu; Julie M Gastier-Foster; Uta Francke; Stephen M Borowitz; James L Sutphen; TE Kelly
Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome.
American journal of medical genetics 2000;90(5):390-7.
1997: ML Reinagel; M Gezen; PJ Ferguson; SE Kuhn; Edward N Martin; Ronald P Taylor
The primate erythrocyte complement receptor (CR1) as a privileged site: binding of immunoglobulin G to erythrocyte CR1 does not target erythrocytes for phagocytosis.
Blood 1997;89(3):1068-77.
1997: Ronald P Taylor; William M Sutherland; Edward N Martin; PJ Ferguson; ML Reinagel; E Gilbert; K Lopez; N L Incardona; Hans D Ochs
Bispecific monoclonal antibody complexes bound to primate erythrocyte complement receptor 1 facilitate virus clearance in a monkey model.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(2):842-50.
1997: Ronald P Taylor; PJ Ferguson; Edward N Martin; James M Cooke; K L Greene; K Grinspun; M Guttman; SE Kuhn
Immune complexes bound to the primate erythrocyte complement receptor (CR1) via anti-CR1 mAbs are cleared simultaneously with loss of CR1 in a concerted reaction in a rhesus monkey model.
Clinical immunology and immunopathology 1997;82(1):49-59.
1996: PJ Ferguson; Frank T Saulsbury; S F Dowell; Thomas J Török; Dean D Erdman; Larry J Anderson
Prevalence of human parvovirus B19 infection in children with Henoch-Schönlein purpura.
Arthritis and rheumatism 1996;39(5):880-1.
1996: PJ Ferguson; Frank T Saulsbury
Successful treatment of chronic Mycobacterium abscessus otitis media with clarithromycin.
The Pediatric infectious disease journal 1996;15(4):384-5.
1995: Ronald P Taylor; PJ Ferguson
Primate erythrocyte (E) complement receptor (CR1) as an anchor site for bispecific-based therapies to clear pathogens or autoantibodies safely from the circulation.
Journal of hematotherapy 1995;4(5):357-62.
1995: PJ Ferguson; Edward N Martin; K L Greene; S Kuhn; David S Cafiso; G Addona; Ronald P Taylor
Antigen-based heteropolymers facilitate, via primate erythrocyte complement receptor type 1, rapid erythrocyte binding of an autoantibody and its clearance from the circulation in rhesus monkeys.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(1):339-47.
1995: PJ Ferguson; C J Reist; Edward N Martin; C Johnson; K L Greene; S Kuhn; J Niebur; W Emlen; Ronald P Taylor
Antigen-based heteropolymers. A potential therapy for binding and clearing autoantibodies via erythrocyte CR1.
Arthritis and rheumatism 1995;38(2):190-200.